CCL2 and diabetes mellitus: In patients with diabetes, carotid PVAT surrounding the atheromatous plaques showed an increase in the mRNA levels of tumour necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1), and interleukin-6 (IL-6) [29].